Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer
Jianguo Li; Nidal Al‐Huniti; Anja Henningsson; Weifeng Tang; Eric Masson
Author Information: Quantitative Clinical Pharmacology, Early Clinical Development, Innovative Medicine and Early Development
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.